WHO ICTRP trial
Monitoring of tacrolimus blood concentrations and evaluation of pregnancy…
ChiCTR2500108296 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500108296 |
|---|---|
| Public title | Monitoring of tacrolimus blood concentrations and evaluation of pregnancy outcomes in patients with connective tissue diseases during pregnancy |
| Scientific title | Monitoring of tacrolimus blood concentrations and evaluation of pregnancy outcomes in patients with connective tissue diseases during pregnancy |
| Primary sponsor | The Second Hospital of Lanzhou University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | connective tissue disease |
| Interventions | Tacrolimus group:Tacrolimus treatment;Non-tacrolimus group:Non-tacrolimus treatment |
| Registration date | Aug 27, 2025 |
| Target size | Tacrolimus group:40;Non-tacrolimus group:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: